Related Articles
Prognosis and endocrine therapy selection for patients with low hormone receptor‑positive breast cancer following neoadjuvant chemotherapy: A retrospective study of 570 patients in China
Predictive value of phosphorylated mammalian target of rapamycin for disease‑free survival in breast cancer patients receiving neoadjuvant chemotherapy
Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy
UCP2 expression may represent a predictive marker of neoadjuvant chemotherapy effectiveness for locally advanced uterine cervical cancer
17p12 deletion in breast cancer predicts resistance to neoadjuvant chemotherapy